A steroid metabolizing gene variant in a polyfactorial model improves risk prediction in a high incidence breast cancer population

Background We have combined functional gene polymorphisms with clinical factors to improve prediction and understanding of sporadic breast cancer risk, particularly within a high incidence Caucasian population.